These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 11278633
21. Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins. Stefanidakis M, Bjorklund M, Ihanus E, Gahmberg CG, Koivunen E. J Biol Chem; 2003 Sep 05; 278(36):34674-84. PubMed ID: 12824186 [Abstract] [Full Text] [Related]
22. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen. Ni F, Konishi Y, Bullock LD, Rivetna MN, Scheraga HA. Biochemistry; 1989 Apr 04; 28(7):3106-19. PubMed ID: 2742828 [Abstract] [Full Text] [Related]
23. Random phage-epitope library based identification of a peptide antagonist of Mac-1 β2 integrin ligand binding. Houimel M, Mazzucchelli L. Matrix Biol; 2012 Jan 04; 31(1):66-77. PubMed ID: 22100634 [Abstract] [Full Text] [Related]
24. Structure-function of the putative I-domain within the integrin beta 2 subunit. Xiong YM, Zhang L. J Biol Chem; 2001 Jun 01; 276(22):19340-9. PubMed ID: 11278448 [Abstract] [Full Text] [Related]
29. Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Aalpha-chain. Suehiro K, Mizuguchi J, Nishiyama K, Iwanaga S, Farrell DH, Ohtaki S. J Biochem; 2000 Oct 01; 128(4):705-10. PubMed ID: 11011154 [Abstract] [Full Text] [Related]
30. Distinct ligand binding sites in the I domain of integrin alpha M beta 2 that differentially affect a divalent cation-dependent conformation. McGuire SL, Bajt ML. J Biol Chem; 1995 Oct 27; 270(43):25866-71. PubMed ID: 7592772 [Abstract] [Full Text] [Related]
31. Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen. Podolnikova NP, Yakubenko VP, Volkov GL, Plow EF, Ugarova TP. J Biol Chem; 2003 Aug 22; 278(34):32251-8. PubMed ID: 12799374 [Abstract] [Full Text] [Related]
32. Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor c-terminal tail. Bishayee A, Beguinot L, Bishayee S. Mol Biol Cell; 1999 Mar 22; 10(3):525-36. PubMed ID: 10069801 [Abstract] [Full Text] [Related]
37. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain. Johnson G, Swart C, Moore SW. Biochem J; 2008 May 01; 411(3):507-14. PubMed ID: 18215127 [Abstract] [Full Text] [Related]
38. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain. Oxvig C, Lu C, Springer TA. Proc Natl Acad Sci U S A; 1999 Mar 02; 96(5):2215-20. PubMed ID: 10051621 [Abstract] [Full Text] [Related]
39. Fine mapping of inhibitory anti-alpha5 monoclonal antibody epitopes that differentially affect integrin-ligand binding. Burrows L, Clark K, Mould AP, Humphries MJ. Biochem J; 1999 Dec 01; 344 Pt 2(Pt 2):527-33. PubMed ID: 10567237 [Abstract] [Full Text] [Related]
40. Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit. Mould AP, Askari JA, Humphries MJ. J Biol Chem; 2000 Jul 07; 275(27):20324-36. PubMed ID: 10764748 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]